Educational Recommendations on Selected Analytical and Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure: A Report from the IFCC Committee on Clinical Applications of Cardiac Bio-Markers




Kaysak PA, Lam CSP, Saenger AK, Jaffe AS, Collinson P, Pulkki K, Omland T, Lefeyre G, Body R, Ordonez-Llanos J, Apple FS

PublisherAMER ASSOC CLINICAL CHEMISTRY

Minneapolis

2019

Clinical Chemistry

CLINICAL CHEMISTRY

CLIN CHEM

65

10

1221

1227

7

0009-9147

1530-8561

DOIhttps://doi.org/10.1373/clinchem.2019.306621

10.1373/clinchem.2019.306621



The IFCC Committee on Clinical Applications of Cardiac Bio-Markers (C-CB) has directives and initiatives focused on providing evidence-based educational resources to aid and improve understanding around key analytical and clinical aspects of cardiac biomarkers used in clinical practice and the research setting. As a task force, we have previously published position statements and recommendations focused on use and analytical aspects of high-sensitivity cardiac troponin assays. The current educational document is the first from the C-CB highlighting important biochemical, analytical, and clinical aspects as they relate to the natriuretic peptides (NPs), including B-type natriuretic peptide (BNP) and N-terminal pro-B-type natriuretic peptide (NTproBNP), with a focus on heart failure. (C) 2019 American Association for Clinical Chemistry



Last updated on 2024-26-11 at 15:43